America’s leading congress for diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. Join 1500+ leaders in Boston to explore breakthroughs in multiomic data, AI, genomics, and digital health in the
Background: Traditional clinical trial evaluations heavily rely on the Average Treatment Effect (ATE), a metric that can obscure substantial heterogeneity in individual patient res…
An audience of 6 companies, parsed from the program.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.
67% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.
Of 6 on the bill · classified by free-text title
Tiers were not disclosed for this event.